GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Cardio Diagnostics Holdings CDIO · USD

Health Care · US listing · 🇺🇸 United States

Compare

1.82

+10.30%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$14,825

FY2020FY2025

Net income

−$6.5m

FY2020FY2025

Free cash flow

−$5.9m

FY2020FY2025

Shareholders' equity

$7.0m

FY2020FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020
Revenue$14,825$34,890$17,065$950$901—
Gross profit$14,825$34,890$17,065$950$901—
Research and development$641,212$227,966$145,182$40,448$31,468$1,500
Operating income−$6.5m−$8.4m−$1.6m−$4.7m−$620,448−$609,164
Net income−$6.5m−$8.4m−$8.4m−$4.7m−$620,448−$605,164
Diluted earnings per share-3.56-0.18-0.41-0.49-0.08-0.20

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020
Total assets$7.8m$10.6m$4.5m$6.2m$1.1m$446,375
Cash and short-term investments$5.1m$7.8m$1.3m$4.1m$512,767$237,087
Total liabilities$793,061$1.1m$1.5m$1.9m$33,885$386,010
Debt$695,619$969,863$1.3m$849,032——
Shareholders' equity$7.0m$9.6m$3.0m$4.3m$1.1m$60,365
Shares outstanding2m46m21m10m8m3m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020
Cash from operations−$5.7m−$5.0m−$5.7m−$5.1m−$585,291$25,859
Capital spending−$187,317−$404,190−$794,291−$76,154−$114,029−$29,910
Free cash flow−$5.9m−$5.4m−$6.5m−$5.2m−$699,320−$4,051

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$5,360$2,680$3,555$2,855$7,475$940$4,512$6,580
Gross profit$5,360−$91,972$3,555$2,855$7,475$940$4,512$6,580
Operating income−$1.5m−$1.8m−$1.5m−$1.7m−$1.7m−$1.6m−$1.5m−$1.4m
Net income−$1.5m−$1.8m−$1.5m−$1.7m−$1.7m−$1.6m−$1.5m−$1.4m
Diluted earnings per share-0.51-0.60-0.80-0.94-0.92-0.90-0.03-0.03
Cash from operations−$1.0m−$1.0m−$1.0m−$1.0m−$1.0m−$1.0m−$1.0m−$1.0m
Total assets$7.9m$9.6m$7.8m$8.8m$10.4m$12.3m$10.6m$4.5m
Cash and short-term investments$5.6m$7.1m$5.1m$6.4m$8.0m$9.7m$7.8m$2.0m
Debt$229,115$368,473$507,397$247,714$244,182$240,707$544,034$233,871
Shareholders' equity$7.4m$8.9m$7.0m$8.2m$9.7m$11.4m$9.6m$3.7m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue149.9%——
Operating income11.6%60.5%—
Net income11.7%60.8%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin100.0%100.0%——
Operating margin-29870.2%-31232.6%——
Net margin-29933.9%-41221.7%——

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022
Price to earnings-0.5-48.9-59.5-21.1
Price to sales205.0———

Share price return

Finished calendar years

2025202420232022
Return-80%-62%131%-84%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 30-to-1 reverse split · 13 May 2025
  • 1-to-1 reverse split · 26 Oct 2022

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.